[1] 赵振理,畅继武,孙光.AY887902全长扩增及其生物信息学研究[J].中国药物与临床,2014,14(1):5-8. [2] 胡少华,赵振理,孙光,等.蛋白AAX14401相应抗体的制备及鉴定[J].临床医药实践,2015,24(9):683-685. [3] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136(5):E359-386. [4] Yang SJ, Wang DD, Li J, et al. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer[J]. Gene, 2017, 623:5-14. [5] Sawers L, Ferguson MJ, Ihrig BR, et al. Glutathione S-transferase P1(GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines[J]. Br J Cancer, 2014, 111(6):1150-1158. [6] Fang C, Wei XM, Zeng XT, et al. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer:a meta-analysis of 19 case-control studies[J]. BMC Cancer, 2015, 15:920. [7] Gu JD, Hua F, Mei CR, et al. HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population[J]. Acta Pharmacol Sin, 2014, 35(5):636-644. [8] Kumamoto K, Ishibashi K, Okada N, et al. Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients[J]. Oncol Lett, 2013, 6(3):648-654. [9] Zhang J, Grek C, Ye ZW, et al. Pleiotropic functions of glutathione S-transferase P[J]. Adv Cancer Res, 2014, 122:143-175. [10] Djukic T, Simic T, Pljesa-Ercegovac M, et al. Upregulated glutathione transferase omega-1 correlates with progression of urinary bladder carcinoma[J]. Redox Rep, 2017, 22(6):486-492. [11] 唐荣金,何小龙,朱海琴,等.GSTP1表达下调促进膀胱癌细胞T24凋亡[J].安徽医科大学学报,2017,52(10):1463-1467. [12] Uchida Y, Chiyomaru T, Enokida H, et al. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines[J]. Urol Oncol, 2013, 31(1):115-123. [13] Wang Z, Xue L, Chong T, et al. Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk[J]. Tumour Biol, 2013, 34(3):1651-1657. [14] Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, et al. Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways[J]. Urol Oncol, 2011, 29(1):70-77. [15] Wang CS, Wei SJ, Zhao GG. Correlation of sensitivity of chemotherapy drugs with the originated tissue, clinical stage and pathological type of carcinoma[J]. Sect Clin Biochem Lab Med Foreign Med Sci, 2005, 26(4):209-212. [16] 夏冰,陈晓东,刘大志,等.乳腺癌化疗药物的体外敏感性与临床病理的关系[J].肿瘤研究与临床,2008,20(11):745-748. [17] Gao L, Fang YQ, Zhang TY, et al.GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression[J]. Int J Clin Exp Med, 2014, 7(9):2984-2991. [18] Berendsen CL, Peters WH, Scheffer PG, et al. Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder[J].Urology,1997,49(4):644-651. |